Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil.

Authors:
Address: Virology and Experimental Therapy Laboratory, Aggeu Magalhães Research Center, Fiocruz, Recife, Pernambuco, Brazil. abm@cpqam.fiocruz.br
Journal:

Publication:
Free Text: Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil.

abstract

From September 2005 to March 2007, 238 individuals being vaccinated for the first time with the yellow fever (YF) -17DD vaccine were enrolled in a cohort established in Recife, Brazil. A prospective study indicated that, after immunization, anti-YF immunoglobulin M (IgM) and anti-YF IgG were present in 70.6% (IgM) and 98.3% (IgG) of the vaccinated subjects. All vaccinees developed protective immunity, which was detected by the plaque reduction neutralization test (PRNT) with a geometric mean titer of 892. Of the 238 individuals, 86.6% had IgG antibodies to dengue virus; however, the presence of anti-dengue IgG did not interfere significantly with the development of anti-YF neutralizing antibodies. In a separate retrospective study of individuals immunized with the 17DD vaccine, the PRNT values at 5 and 10 years post-vaccination remained positive but showed a significant decrease in neutralization titer (25% with PRNT titers < 100 after 5 years and 35% after 10 years).

Related Articles
Evaluation of an indirect immunofluorescence assay for detection of immunoglobulin M (IgM) and IgG antibodies against yellow fever virus.
Clin Vaccine Immunol. 2008
Evaluation of an indirect immunofluorescence assay for detection of immunoglobulin M (IgM) and IgG antibodies against yellow fever virus.
Niedrig M, Kürsteiner O, Herzog C, Sonnenberg K. Clin Vaccine Immunol. 2008 Feb; 15(2):177-81. Epub 2007 Nov 28.
The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil.
Vaccine. 2006
The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil.
Suzano CE, Amaral E, Sato HK, Papaiordanou PM, Campinas Group on Yellow Fever Immunization during Pregnancy. Vaccine. 2006 Feb 27; 24(9):1421-6. Epub 2005 Oct 3.
Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity.
Hum Vaccin. 2010
Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity.
Nasveld PE, Marjason J, Bennett S, Aaskov J, Elliott S, McCarthy K, Kanesa-Thasan N, Feroldi E, Reid M. Hum Vaccin. 2010 Nov; 6(11):906-14. Epub 2010 Nov 1.
Review [Yellow fever vaccination in non-immunocompetent patients].
Med Mal Infect. 2008
Review [Yellow fever vaccination in non-immunocompetent patients].
Bruyand M, Receveur MC, Pistone T, Verdière CH, Thiebaut R, Malvy D. Med Mal Infect. 2008 Oct; 38(10):524-32.
Review Yellow fever vaccine: past, present and future.
Expert Opin Biol Ther. 2008
Review Yellow fever vaccine: past, present and future.
Roukens AH, Visser LG. Expert Opin Biol Ther. 2008 Nov; 8(11):1787-95.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.